Clinical Trial

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to assess the feasibility and safety of oral nicotinamide (NAM; a derivative of vitamin B3 \[niacin\]) and vitamin A in a high-risk population of kidney transplant recipients with a history of skin cancer to generate preliminary data for future cancer prevention clinical trials.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-01-18.
Status change: Not Yet Recruiting → Recruiting 2026-03-18
Trial Details
NCT Number NCT05702398
Lead Sponsor Rhode Island Hospital
Conditions Skin Cancer, Kidney Transplant Recipients
Enrollment 30 participants
Start Date 2023-04-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-20